Literature DB >> 21486984

JAMA patient page. Hepatitis B.

Janet M Torpy, Alison E Burke, Robert M Golub.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21486984     DOI： 10.1001/jama.305.14.1500

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  5 in total

1.  Prevalence of hepatitis B in insular regions of southeast China: a community-based study.

Authors:  Ping Chen; Chengbo Yu; Bing Ruan; Shigui Yang; Jingjing Ren; Weijian Xu; Zhuanbo Luo; Lanjuan Li
Journal:  PLoS One       Date:  2013-02-20       Impact factor: 3.240

2.  Application of a hybrid method combining grey model and back propagation artificial neural networks to forecast hepatitis B in china.

Authors:  Ruijing Gan; Xiaojun Chen; Yu Yan; Daizheng Huang
Journal:  Comput Math Methods Med       Date:  2015-02-26       Impact factor: 2.238

3.  Protective immune barrier against hepatitis B is needed in individuals born before infant HBV vaccination program in China.

Authors:  Shigui Yang; Chengbo Yu; Ping Chen; Min Deng; Qing Cao; Yiping Li; Jingjing Ren; Kaijin Xu; Jun Yao; Tiansheng Xie; Chencheng Wang; Yuanxia Cui; Cheng Ding; Guo Tian; Bing Wang; Xiaoyan Zhang; Bing Ruan; Lanjuan Li
Journal:  Sci Rep       Date:  2015-12-14       Impact factor: 4.379

4.  A system dynamics modelling simulation based on a cohort of hepatitis B epidemic research in east China community.

Authors:  Zhixin Yu; Min Deng; Chunting Peng; Xue Song; Yi Chen; Xue Zhang; Qiuxia Liu; Yuchuan Li; Haiyin Jiang; Xiaolan Xu; Liya Pan; Jing Yuan; Bing Ruan
Journal:  Epidemiol Infect       Date:  2019-02-28       Impact factor: 2.451

5.  Effectiveness of HBV vaccination in infants and prediction of HBV prevalence trend under new vaccination plan: findings of a large-scale investigation.

Authors:  Shi-gui Yang; Bing Wang; Ping Chen; Cheng-bo Yu; Min Deng; Jun Yao; Chun-xia Zhu; Jing-jing Ren; Wei Wu; Bin Ju; Jian-feng Shen; Yu Chen; Ming D Li; Bing Ruan; Lanjuan Li
Journal:  PLoS One       Date:  2012-10-19       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.